BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 28241076)

  • 1. Characterisation of liver fat in the UK Biobank cohort.
    Wilman HR; Kelly M; Garratt S; Matthews PM; Milanesi M; Herlihy A; Gyngell M; Neubauer S; Bell JD; Banerjee R; Thomas EL
    PLoS One; 2017; 12(2):e0172921. PubMed ID: 28241076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow fat content is correlated with hepatic fat content in paediatric non-alcoholic fatty liver disease.
    Yu NY; Wolfson T; Middleton MS; Hamilton G; Gamst A; Angeles JE; Schwimmer JB; Sirlin CB
    Clin Radiol; 2017 May; 72(5):425.e9-425.e14. PubMed ID: 28063601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of a high-SNR chemical-shift-encoded MRI with complex reconstruction for proton density fat fraction (PDFF) estimation overall and in the low-fat range.
    Park CC; Hooker C; Hooker JC; Bass E; Haufe W; Schlein A; Covarrubias Y; Heba E; Bydder M; Wolfson T; Gamst A; Loomba R; Schwimmer J; Hernando D; Reeder SB; Middleton M; Sirlin CB; Hamilton G
    J Magn Reson Imaging; 2019 Jan; 49(1):229-238. PubMed ID: 29707848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inter-reader agreement of magnetic resonance imaging proton density fat fraction and its longitudinal change in a clinical trial of adults with nonalcoholic steatohepatitis.
    Hooker JC; Hamilton G; Park CC; Liao S; Wolfson T; Dehkordy SF; Hong CW; Mamidipalli A; Gamst A; Loomba R; Sirlin CB
    Abdom Radiol (NY); 2019 Feb; 44(2):482-492. PubMed ID: 30128694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased severity of liver fat content and liver fibrosis in non-alcoholic fatty liver disease correlate with epicardial fat volume in type 2 diabetes: A prospective study.
    Brouha SS; Nguyen P; Bettencourt R; Sirlin CB; Loomba R
    Eur Radiol; 2018 Apr; 28(4):1345-1355. PubMed ID: 29058029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in multi-echo chemical shift encoded MRI proton density fat fraction estimation based on multifrequency fat peaks selection in non-alcoholic fatty liver disease patients.
    Martí-Aguado D; Alberich-Bayarri Á; Martín-Rodríguez JL; França M; García-Castro F; González-Cantero J; González-Cantero Á; Martí-Bonmatí L
    Clin Radiol; 2020 Nov; 75(11):880.e5-880.e12. PubMed ID: 32888653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-sectional correlation between hepatic R2* and proton density fat fraction (PDFF) in children with hepatic steatosis.
    Mamidipalli A; Hamilton G; Manning P; Hong CW; Park CC; Wolfson T; Hooker J; Heba E; Schlein A; Gamst A; Durelle J; Paiz M; Middleton MS; Schwimmer JB; Sirlin CB
    J Magn Reson Imaging; 2018 Feb; 47(2):418-424. PubMed ID: 28543915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between Liver MRI Proton Density Fat Fraction and Liver Disease Risk.
    Xia T; Du M; Li H; Wang Y; Zha J; Wu T; Ju S
    Radiology; 2023 Oct; 309(1):e231007. PubMed ID: 37874242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reference range of liver corrected T1 values in a population at low risk for fatty liver disease-a UK Biobank sub-study, with an appendix of interesting cases.
    Mojtahed A; Kelly CJ; Herlihy AH; Kin S; Wilman HR; McKay A; Kelly M; Milanesi M; Neubauer S; Thomas EL; Bell JD; Banerjee R; Harisinghani M
    Abdom Radiol (NY); 2019 Jan; 44(1):72-84. PubMed ID: 30032383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic Resonance Imaging Proton Density Fat Fraction Associates With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Ajmera V; Park CC; Caussy C; Singh S; Hernandez C; Bettencourt R; Hooker J; Sy E; Behling C; Xu R; Middleton MS; Valasek MA; Faulkner C; Rizo E; Richards L; Sirlin CB; Loomba R
    Gastroenterology; 2018 Aug; 155(2):307-310.e2. PubMed ID: 29660324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI-determined liver proton density fat fraction, with MRS validation: Comparison of regions of interest sampling methods in patients with type 2 diabetes.
    Vu KN; Gilbert G; Chalut M; Chagnon M; Chartrand G; Tang A
    J Magn Reson Imaging; 2016 May; 43(5):1090-9. PubMed ID: 26536609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Fatty Liver Disease and Hepatic Iron Overload in a Northeastern German Population by Using Quantitative MR Imaging.
    Kühn JP; Meffert P; Heske C; Kromrey ML; Schmidt CO; Mensel B; Völzke H; Lerch MM; Hernando D; Mayerle J; Reeder SB
    Radiology; 2017 Sep; 284(3):706-716. PubMed ID: 28481195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy and precision of proton density fat fraction measurement across field strengths and scan intervals: A phantom and human study.
    Kim HJ; Cho HJ; Kim B; You MW; Lee JH; Huh J; Kim JK
    J Magn Reson Imaging; 2019 Jul; 50(1):305-314. PubMed ID: 30430684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free-breathing 3-D quantification of infant body composition and hepatic fat using a stack-of-radial magnetic resonance imaging technique.
    Armstrong T; Ly KV; Ghahremani S; Calkins KL; Wu HH
    Pediatr Radiol; 2019 Jun; 49(7):876-888. PubMed ID: 31001664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional analysis of pancreatic fat by fat-water magnetic resonance imaging provides detailed characterization of pancreatic steatosis with improved reproducibility.
    Kato S; Iwasaki A; Kurita Y; Arimoto J; Yamamoto T; Hasegawa S; Sato T; Imajo K; Hosono K; Kobayashi N; Yoneda M; Higurashi T; Kubota K; Utsunomiya D; Nakajima A
    PLoS One; 2019; 14(12):e0224921. PubMed ID: 31790429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic R2* is more strongly associated with proton density fat fraction than histologic liver iron scores in patients with nonalcoholic fatty liver disease.
    Bashir MR; Wolfson T; Gamst AC; Fowler KJ; Ohliger M; Shah SN; Alazraki A; Trout AT; Behling C; Allende DS; Loomba R; Sanyal A; Schwimmer J; Lavine JE; Shen W; Tonascia J; Van Natta ML; Mamidipalli A; Hooker J; Kowdley KV; Middleton MS; Sirlin CB;
    J Magn Reson Imaging; 2019 May; 49(5):1456-1466. PubMed ID: 30318834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a motion-robust 2D sequential technique for quantification of hepatic proton density fat fraction during free breathing.
    Pooler BD; Hernando D; Ruby JA; Ishii H; Shimakawa A; Reeder SB
    J Magn Reson Imaging; 2018 Dec; 48(6):1578-1585. PubMed ID: 29665193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of liver iron by magnetic resonance imaging in the UK Biobank population.
    McKay A; Wilman HR; Dennis A; Kelly M; Gyngell ML; Neubauer S; Bell JD; Banerjee R; Thomas EL
    PLoS One; 2018; 13(12):e0209340. PubMed ID: 30576354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of liver, pancreas, kidney, and vertebral body MRI-PDFF in non-alcoholic fatty liver disease.
    Idilman IS; Tuzun A; Savas B; Elhan AH; Celik A; Idilman R; Karcaaltincaba M
    Abdom Imaging; 2015 Aug; 40(6):1512-9. PubMed ID: 25715922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic profiling of MRI-measured liver fat in the UK Biobank.
    Gnatiuc Friedrichs L; Trichia E; Aguilar-Ramirez D; Preiss D
    Obesity (Silver Spring); 2023 Apr; 31(4):1121-1132. PubMed ID: 36872307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.